<div id="readability-page-1"><div>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.<ul><li>Baird raised the price target for Tesla, Inc. TSLA from $280 to $480. Baird analyst Ben Kallo maintained an Outperform rating. Tesla shares closed at $479.86 on Tuesday. See how other analysts view this stock.</li><li>Truist Securities raised the price target for Community Healthcare Trust Incorporated CHCT from $22 to $23. Truist Securities analyst Michael Lewis maintained a Buy rating. Community Healthcare Trust shares closed at $18.85 on Tuesday. See how other analysts view this stock.</li><li>Wells Fargo boosted the price target for Targa Resources Corp. TRGP from $190 to $204. Wells Fargo analyst Michael Blum maintained an Overweight rating. Targa Resources shares closed at $181.22 on Tuesday. See how other analysts view this stock.</li><li>JMP Securities cut Bicycle Therapeutics plc BCYC price target from $32 to $26. JMP Securities analyst Reni Benjamin maintained a Market Outperform rating. Bicycle Therapeutics shares settled at $15.14 on Tuesday. See how other analysts view this stock.</li><li>Cantor Fitzgerald raised Archer Aviation Inc. ACHR price target from $10 to $13. Cantor Fitzgerald analyst Andres Sheppard maintained an Overweight rating. Archer Aviation shares closed at $9.09 on Tuesday. See how other analysts view this stock.</li><li>Morgan Stanley boosted Zoom Communications Inc. ZM price target from $86 to $96. Morgan Stanley analyst Meta Marshall maintained an Equal-Weight rating. Zoom Communications shares closed at $84.60 on Tuesday. See how other analysts view this stock.</li><li>Alliance Global Partners raised Vitesse Energy, Inc. VTS price target from $26 to $29. Alliance Global Partners analyst Jeff Grampp upgraded the stock from Neutral to Buy. Vitesse Energy shares closed at $26.19 on Tuesday. See how other analysts view this stock.</li><li>B of A Securities cut the price target for 4D Molecular Therapeutics, Inc. FDMT from $79 to $46. B of A Securities analyst Tazeen Ahmad maintained a Buy rating. 4D Molecular Therapeutics shares settled at $6.32 on Tuesday. See how other analysts view this stock.</li><li>JP Morgan raised Amazon.com, Inc. AMZN price target from $250 to $280. JP Morgan analyst Doug Anmuth maintained an Overweight rating. Amazon shares closed at $231.15 on Tuesday. See how other analysts view this stock.</li><li>JP Morgan increased Alphabet Inc. GOOGL price target from $212 to $232. JP Morgan analyst Doug Anmuth maintained an Overweight rating. Alphabet shares closed at $195.42 on Tuesday. See how other analysts view this stock.</li></ul>Considering buying AMZN stock? Here’s what analysts think: <figure><img width="1024" height="578" src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18101756/image-160-1024x578.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18101756/image-160-1024x578.png"/></figure>Read This Next: <ul><li>Top 3 Health Care Stocks That May Explode In Q4</li></ul></div></div>

AMZN

AMZU

AMZD

Top Wall Street analysts have updated their price targets for several companies, including Amazon, which saw its target raised by JP Morgan. Other notable changes include Tesla, Community Healthcare Trust, Targa Resources, and Zoom Communications. Analysts maintained various ratings such as Outperform and Buy for these stocks. The updates reflect a mix of upgrades and downgrades across the board, indicating shifting market sentiments. For a complete view of all analyst rating changes, refer to the analyst ratings page.

- Top Wall Street analysts have revised their price targets and ratings for several companies, including Tesla, Community Healthcare Trust, and Amazon.  
- Baird, Truist Securities, and JP Morgan have raised their price targets while maintaining positive ratings, whereas JMP Securities cut the target for Bicycle Therapeutics but kept a favorable rating.  
- The article provides a comprehensive overview of analyst rating changes, highlighting the closing prices of the stocks on Tuesday.

Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday